Co-Founder, BuddyTV
VP of Research and Special Initiatives, Google
President & CEO, Indiana Biosciences Research Institute
Founder and CEO, Lighter Capital
Vice President for Research at UT Health Science Center at San Antonio
Senior health advisor for Esri
Nobel Laureate, Professor of Biology, Caltech
CEO and Founder, Techstars
The Affordable Care Act created a pathway for FDA approval of biosimilars, and the agency has been developing the rules that will govern this new area. Biocom has organized a discussion about the challenges state and federal authorities face in creating a system that will work for both biosimilar innovators and manufacturers. This session offers an opportunity to learn what the real potential of this segment will be as these products come closer to commercialization. More information and online registration is here.